![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 51, 40641-40648, December 22, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the European Molecular Biology Laboratory, Meyerhofstrasse 1, 69117 Heidelberg, Germany
We have investigated the ability of the
mitogen-activated protein kinase (MAPK) kinase MKK6 to activate
different members of the p38 subfamily of MAPKs and found that some
MKK6 mutants can efficiently activate p38
Differential Activation of p38 Mitogen-activated Protein
Kinase Isoforms Depending on Signal Strength*
,
,
but not p38
. In
contrast, a constitutively active MKK6 mutant activated both p38 MAPK
isoforms to similar extents. The same results were obtained upon
co-expression in Xenopus oocytes and in vitro
using either MKK6 immunoprecipitates from transfected cells or
bacterially produced recombinant proteins. We also found that the
preferential activation of p38
by MKK6 correlated with more
efficient binding of MKK6 to p38
than to p38
. Furthermore,
increasing concentrations of constitutively active MKK6 differentially
activated either p38
alone (low MKK6 activity) or both p38
and
p38
(high MKK6 activity), both in vitro and in injected
oocytes. The determinants for selectivity are located at the
carboxyl-terminal lobe of p38 MAPKs but do not correspond to the
activation loop or common docking sequences. We also showed that
different stimuli can induce different levels of endogenous MKK6
activity that correlate with differential activation of p38 MAPKs. Our
results suggest that the level of MKK6 activity triggered by a given
stimulus may determine the pattern of downstream p38 MAPK activation in
the particular response.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
These authors contributed equally to this work.
§
To whom correspondence should be addressed. Tel.:
49-6221-387426; Fax: 49-6221-387166; E-mail:
Nebreda@EMBL-heidelberg.de.
This article has been cited by other articles:
![]() |
R. J. Hill, K. Dabbagh, D. Phippard, C. Li, R. T. Suttmann, M. Welch, E. Papp, K. W. Song, K.-c. Chang, D. Leaffer, et al. Pamapimod, a Novel p38 Mitogen-Activated Protein Kinase Inhibitor: Preclinical Analysis of Efficacy and Selectivity J. Pharmacol. Exp. Ther., December 1, 2008; 327(3): 610 - 619. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-R. Ki, H.-R. Lee, M.-J. Goo, I.-H. Hong, S.-H. Do, D.-H. Jeong, H.-J. Yang, D.-W. Yuan, J.-K. Park, and K.-S. Jeong Differential regulation of ERK1/2 and p38 MAP kinases in VacA-induced apoptosis of gastric epithelial cells Am J Physiol Gastrointest Liver Physiol, March 1, 2008; 294(3): G635 - G647. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.S. Patil and K.L. Kirkwood p38 MAPK Signaling in Oral-related Diseases J. Dent. Res., September 1, 2007; 86(9): 812 - 825. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-S. Keum, S. Yu, P. P.-J. Chang, X. Yuan, J.-H. Kim, C. Xu, J. Han, A. Agarwal, and A.-N. T. Kong Mechanism of Action of Sulforaphane: Inhibition of p38 Mitogen-Activated Protein Kinase Isoforms Contributing to the Induction of Antioxidant Response Element-Mediated Heme Oxygenase-1 in Human Hepatoma HepG2 Cells. Cancer Res., September 1, 2006; 66(17): 8804 - 8813. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Nony, S. B. Kennett, W. C. Glasgow, K. Olden, and J. D. Roberts 15(S)-Lipoxygenase-2 Mediates Arachidonic Acid-stimulated Adhesion of Human Breast Carcinoma Cells through the Activation of TAK1, MKK6, and p38 MAPK J. Biol. Chem., September 9, 2005; 280(36): 31413 - 31419. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Fernando, W. Deng, B. Pekalska, Y. DeRepentigny, R. Kothary, J. F. Kelly, and L. A. Megeney Active Kinase Proteome Screening Reveals Novel Signal Complexity in Cardiomyopathy Mol. Cell. Proteomics, May 1, 2005; 4(5): 673 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Wang, M. Yerukhimovich, W. A. Gaarde, I. J. Popoff, and C. M. Doerschuk MKK3 and -6-dependent activation of p38{alpha} MAP kinase is required for cytoskeletal changes in pulmonary microvascular endothelial cells induced by ICAM-1 ligation Am J Physiol Lung Cell Mol Physiol, February 1, 2005; 288(2): L359 - L369. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gonzalez, G. Tripathi, E. J. Carter, L. J. Cobb, D. A. M. Salih, F. A. Lovett, C. Holding, and J. M Pell Akt2, a Novel Functional Link between p38 Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase Pathways in Myogenesis Mol. Cell. Biol., May 1, 2004; 24(9): 3607 - 3622. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pramanik, X. Qi, S. Borowicz, D. Choubey, R. M. Schultz, J. Han, and G. Chen p38 Isoforms Have Opposite Effects on AP-1-dependent Transcription through Regulation of c-Jun. THE DETERMINANT ROLE OF THE ISOFORMS IN THE p38 MAPK SIGNAL SPECIFICITY J. Biol. Chem., February 7, 2003; 278(7): 4831 - 4839. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ambrosino, G. Mace, S. Galban, C. Fritsch, K. Vintersten, E. Black, M. Gorospe, and A. R. Nebreda Negative Feedback Regulation of MKK6 mRNA Stability by p38{alpha} Mitogen-Activated Protein Kinase Mol. Cell. Biol., January 1, 2003; 23(1): 370 - 381. [Abstract] [Full Text] |
||||
![]() |
K. Matsuda, T. Idezawa, X. J. You, N. H. Kothari, H. Fan, and M. Korc Multiple Mitogenic Pathways in Pancreatic Cancer Cells Are Blocked by a Truncated Epidermal Growth Factor Receptor Cancer Res., October 1, 2002; 62(19): 5611 - 5617. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Eriksson and S. Leppa Mitogen-activated Protein Kinases and Activator Protein 1 Are Required for Proliferation and Cardiomyocyte Differentiation of P19 Embryonal Carcinoma Cells J. Biol. Chem., May 3, 2002; 277(18): 15992 - 16001. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.J. Webb, J.R. McPherson, K. Pahan, and S. Koka Regulation of TNF-{alpha}-induced IL-6 Production in MG-63 Human Osteoblast-like Cells J. Dent. Res., January 1, 2002; 81(1): 17 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Driggers, J. H. Segars, and D. M. Rubino The Proto-oncoprotein Brx Activates Estrogen Receptor beta by a p38 Mitogen-activated Protein Kinase Pathway J. Biol. Chem., December 7, 2001; 276(50): 46792 - 46797. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Dashti, T. Efimova, and R. L. Eckert MEK7-dependent Activation of p38 MAP Kinase in Keratinocytes J. Biol. Chem., March 9, 2001; 276(11): 8059 - 8063. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Dashti, T. Efimova, and R. L. Eckert MEK6 Regulates Human Involucrin Gene Expression via a p38alpha - and p38delta -dependent Mechanism J. Biol. Chem., July 13, 2001; 276(29): 27214 - 27220. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |